Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
Krebs Biochem.&Inds
|
Quest Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.74 % | 56.46 % | 30.21 % |
|
5yr average Equity Multiplier
|
1.68 | -2.97 | 2.94 |
|
5yr Average Asset Turnover Ratio
|
1.03 | 0.3 | 1.51 |
|
5yr Avg Net Profit Margin
|
9.45 % | -60.0 % | 7.37 % |
|
Price to Book
|
3.82 | 0.0 | 0.0 |
|
P/E
|
234.79 | 0.0 | 11.97 |
|
5yr Avg Cash Conversion Cycle
|
34.28 Days | -861.42 Days | 1.67 Days |
|
Inventory Days
|
40.18 Days | 115.42 Days | 28.09 Days |
|
Days Receivable
|
87.78 Days | 8.79 Days | 95.81 Days |
|
Days Payable
|
76.54 Days | 408.94 Days | 139.44 Days |
|
5yr Average Interest Coverage Ratio
|
12.13 | -5.02 | 14.47 |
|
5yr Avg ROCE
|
20.0 % | -22.06 % | 39.56 % |
|
5yr Avg Operating Profit Margin
|
14.46 % | -38.55 % | 11.77 % |
|
5 yr average Debt to Equity
|
0.3 | -2.12 | 0.32 |
|
5yr CAGR Net Profit
|
13.98 % | -7.31 % | 72.53 % |
|
5yr Average Return on Assets
|
9.66 % | -17.59 % | 10.78 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | 72.74 % | 66.21 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | 0.0 | 0.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Auro Laboratories
|
Krebs Biochem.&Inds
|
Quest Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|